NO20013891L - Compositions comprising citalopram - Google Patents

Compositions comprising citalopram

Info

Publication number
NO20013891L
NO20013891L NO20013891A NO20013891A NO20013891L NO 20013891 L NO20013891 L NO 20013891L NO 20013891 A NO20013891 A NO 20013891A NO 20013891 A NO20013891 A NO 20013891A NO 20013891 L NO20013891 L NO 20013891L
Authority
NO
Norway
Prior art keywords
citalopram
pharmaceutically acceptable
mixture
compositions
acceptable salt
Prior art date
Application number
NO20013891A
Other languages
Norwegian (no)
Other versions
NO20013891D0 (en
Inventor
Ken Liljegren
Per Holm
Ole Nielsen
Swen Wagner
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20013891(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20013891D0 publication Critical patent/NO20013891D0/en
Publication of NO20013891L publication Critical patent/NO20013891L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Abstract

En fast, unitær doseringsform som omfatter citalopram,. som prepareres ved direkte kompresjon av en blanding av citalopram-base eller et farmasøytisk akseptabelt salt derav og farmasøytisk akseptable tilsatsstoffer, eller ved fyl-ling av nevnte blanding i en hard gelatinkapsel. Store krystaller av et farmasøytisk akseptabelt salt av citalopram og en metode for fremstillingen av nevnte store krystaller .A solid, unitary dosage form comprising citalopram,. which is prepared by direct compression of a mixture of citalopram base or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable additives, or by filling said mixture into a hard gelatin capsule. Large crystals of a pharmaceutically acceptable salt of citalopram and a method for the preparation of said large crystals.

NO20013891A 2000-08-10 2001-08-09 Compositions comprising citalopram NO20013891L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (2)

Publication Number Publication Date
NO20013891D0 NO20013891D0 (en) 2001-08-09
NO20013891L true NO20013891L (en) 2002-02-11

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013891A NO20013891L (en) 2000-08-10 2001-08-09 Compositions comprising citalopram

Country Status (34)

Country Link
EP (1) EP1318805A2 (en)
JP (1) JP2003531153A (en)
KR (1) KR20030024833A (en)
CN (1) CN1446089A (en)
AR (1) AR030095A1 (en)
AT (1) AT5744U1 (en)
AU (2) AU2001100198B4 (en)
BE (1) BE1013559A6 (en)
BG (1) BG107578A (en)
BR (1) BR0113250A (en)
CA (1) CA2353693C (en)
CH (2) CH694241A5 (en)
CZ (1) CZ2003397A3 (en)
DE (2) DE20113195U1 (en)
EA (1) EA200300247A1 (en)
ES (1) ES2172481B2 (en)
FI (1) FI5176U1 (en)
FR (1) FR2812811B1 (en)
GB (1) GB2368014B (en)
GR (1) GR1004193B (en)
HR (1) HRP20030054A2 (en)
HU (1) HUP0103071A3 (en)
IE (1) IES20010693A2 (en)
IL (1) IL154050A0 (en)
IS (1) IS6021A (en)
IT (1) ITMI20011637A1 (en)
MX (1) MXPA03000837A (en)
NL (1) NL1018741C1 (en)
NO (1) NO20013891L (en)
NZ (1) NZ523785A (en)
PL (1) PL359824A1 (en)
SK (1) SK2842003A3 (en)
WO (1) WO2001080619A2 (en)
YU (1) YU9003A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
ATE388947T1 (en) * 2002-12-23 2008-03-15 Lundbeck & Co As H ESCITALOPRAM HYDROBROMIDE AND A METHOD FOR THE PRODUCTION THEREOF
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (en) * 2006-01-05 2007-12-12 昆明积大制药有限公司 Antidepressant composition containing citalopram and cyclodextrin
GB2480191A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
WO2017020841A1 (en) * 2015-08-03 2017-02-09 深圳信立泰药业股份有限公司 Pharmaceutical composition containing lcz696 and preparation method thereof
WO2022153262A1 (en) * 2021-01-18 2022-07-21 Anton Frenkel Pharmaceutical dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug response by a serotonin 1A receptor antagonist
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
YU9003A (en) 2006-05-25
IES20010693A2 (en) 2002-07-10
NO20013891D0 (en) 2001-08-09
AT5744U1 (en) 2002-11-25
CZ2003397A3 (en) 2003-06-18
JP2003531153A (en) 2003-10-21
CA2353693C (en) 2003-07-22
FR2812811B1 (en) 2006-08-18
BG107578A (en) 2003-09-30
ES2172481B2 (en) 2004-08-01
CH694241A5 (en) 2004-10-15
NZ523785A (en) 2004-09-24
HU0103071D0 (en) 2001-10-28
IL154050A0 (en) 2003-07-31
AU2001279591A1 (en) 2001-11-07
DE10139115A1 (en) 2002-03-28
GB2368014A (en) 2002-04-24
ITMI20011637A0 (en) 2001-07-27
SK2842003A3 (en) 2003-09-11
WO2001080619A2 (en) 2001-11-01
AR030095A1 (en) 2003-08-13
CN1446089A (en) 2003-10-01
GR20010100377A (en) 2002-09-06
AU2001100198B4 (en) 2002-06-13
ITMI20011637A1 (en) 2003-01-27
CA2353693A1 (en) 2002-01-22
WO2001080619A3 (en) 2002-02-21
HUP0103071A3 (en) 2002-12-28
IS6021A (en) 2001-10-20
FR2812811A1 (en) 2002-02-15
BR0113250A (en) 2003-06-24
ES2172481A1 (en) 2002-09-16
FI5176U1 (en) 2001-12-27
BE1013559A6 (en) 2002-03-05
EA200300247A1 (en) 2003-06-26
HRP20030054A2 (en) 2005-02-28
GR1004193B (en) 2003-03-24
GB2368014B (en) 2004-06-23
HUP0103071A2 (en) 2002-05-29
GB0118579D0 (en) 2001-09-19
KR20030024833A (en) 2003-03-26
EP1318805A2 (en) 2003-06-18
AU2001100198A4 (en) 2001-08-16
MXPA03000837A (en) 2003-06-06
NL1018741C1 (en) 2002-02-12
CH694242A5 (en) 2004-10-15
DE20113195U1 (en) 2001-11-15
PL359824A1 (en) 2004-09-06

Similar Documents

Publication Publication Date Title
NO20013891L (en) Compositions comprising citalopram
NO20071498L (en) Substituted acyl hydroxamic acids as well as methods for reducing the TNFα level
DK1117383T3 (en) Dosage forms comprising therapeutic formulation
ES2165833T1 (en) ENTERIC COVERED PHARMACEUTICAL COMPOSITION AND MANUFACTURING PROCEDURE.
CY1107473T1 (en) A PYRIDINE-N-OXIDE PRODUCER, AND THE PROCEDURE FOR TRANSFERING ITS EFFECTIVE PHARMACEUTICAL COMPOSITIONS
AR010634A1 (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLUTION FOR THE ADMINISTRATION OF HIV PROTEASE INHIBITORS
BR0306870A (en) Oral pharmaceutical composition and method for preparing the same
KR850001693A (en) Method for preparing amosulolol hydrochloride long-acting formulation
EP1026157A3 (en) Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
NO20043834L (en) Pharmaceutical composition comprising N - ((1-N-butyl-4-piperidinyl) methyl-3,4-dihydro-2H- (1,3) -oxazino (3,2-A) indole-10-carboxyamide or salts and methods therefore extensive dry granulation
IS3659A7 (en) New method of producing substituted 4-phenyl-4-piperidinecarboxamide which has both local anesthetic and analgesic effect
UY28148A1 (en) SCITALOPRAM BROMHYDRATE AND A METHOD FOR PREPARATION
NO20026154L (en) New Substituted Phthalides, Methods of their Preparation and Pharmaceutical Compositions Containing Them
NO20004919L (en) Process for Preparation of 5-Hydroxybenzo [b] Thiophene-3-Carboxylic Acid Derivatives
NO944214D0 (en) Pharmaceuticals for rectal administration, containing alkylsulfonamides which are HT1 agonists
EA200201024A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING OLIGOSACCHARIDES AND THEIR RECEIVING
DE59913493D1 (en) Two-phase composition with tramadol
EA200300768A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING CYTALOPRA
SE0200256D0 (en) New composition, methods and use
ES8602744A1 (en) Thiophene ring-substituted alpha -(alkylaminopropionyl)-thiophenes and the method for preparing the same
BR0107724A (en) Compound, process for preparing it, pharmaceutical composition and, use of a compound
TR200501142T2 (en) Crystalline Forms of 5-Chloro-2-Methoxy-N- (2- (4-Methoxy-3-Methyl Aminothio Carbonylamino Sulfonylphenyl) Ethyl) Benzamide Sodium Salt.
JPS5271428A (en) Preparation of benzylalcohol derivatives
DK184686A (en) (AMINOALKYLTHIO) HYDROXYDIBENZOXEPINES, A PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
IT8822273A0 (en) PROCEDURE FOR THE PREPARATION OF 1,2-DIFLUORO-1,1,2,2TETACHLOROETHANE SUBSTANTIALLY FREE OF THE 1,1-DIFLUORO 1,2,2,2-TETRACHLOROETHANE ISOMER.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application